Literature DB >> 9255258

Expression of vascular endothelial growth factor and its receptors in pilocytic astrocytoma.

S Y Leung1, A S Chan, M P Wong, S T Yuen, N Cheung, L P Chung.   

Abstract

Vascular endothelial growth factor (VEGF), a potent angiogenic and vascular permeability factor, is important in the angiogenesis of glioblastoma. A major difference between pilocytic astrocytoma, a grade I tumor, and the grade II fibrillary astrocytoma is the vascular proliferation, highly vascularized stroma, and great propensity for cyst formation in the former. In order to explore factors regulating such angiogenesis and cyst formation in pilocytic astrocytoma, we examined expression of VEGF and its receptors (KDR and Flt-1) using in situ hybridization. In all 14 cases a high level of VEGF transcripts could be demonstrated. These were found in specific regions, namely, in the tumor cyst wall, in areas of hyaline cystic degeneration, in stellate reticulated astrocytes around microcysts in the biphasic compact and loose areas, and in tumor cells with degenerative pleomorphic multicoated nuclei. KDR and Flt-1 were expressed in the tumor vasculature, with particularly high levels seen in coiled young proliferating vessels, especially those in the cyst wall. Given the known angiogenic and vascular permeability activities of VEGF, we propose that VEGF plays an important role in molding the characteristic morphologic features of this tumor, namely, the formation of cysts, microcystic pattern, hyaline cystic degeneration, hyaline vessels, and vascular proliferation. Mechanisms that block the VEGF pathway could constitute a potential therapeutic strategy for the treatment of this tumor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9255258     DOI: 10.1097/00000478-199708000-00009

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  13 in total

Review 1.  VEGF in brain tumors.

Authors:  M R Machein; K H Plate
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

2.  Temporal effects of vascular endothelial growth factor and 3,5-cyclic monophosphate on blood-brain barrier solute permeability in vivo.

Authors:  Lingyan Shi; Min Zeng; Bingmei M Fu
Journal:  J Neurosci Res       Date:  2014-07-28       Impact factor: 4.164

3.  Co-existent pilocytic astrocytoma with acute B-cell leukemia within the cerebellum.

Authors:  Richard Hickman; Rebecca Leeman-Neill; Marc Rosenblum; Richard Anderson; James Goldman
Journal:  Neuropathology       Date:  2019-08-13       Impact factor: 1.906

Review 4.  Anti-angiogenic therapy in pediatric neuro-oncology.

Authors:  Mark W Kieran
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

Review 5.  Pediatric cerebellar pilocytic astrocytoma presenting with spontaneous intratumoral hemorrhage.

Authors:  Carmine Antonio Donofrio; Filippo Gagliardi; Marcella Callea; Camillo Ferrari da Passano; Maria Rosa Terreni; Andrea Cavalli; Alfio Spina; Stefania Acerno; Michele Bailo; Samer K Elbabaa; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2018-03-22       Impact factor: 3.042

6.  Targeted therapy in renal cancer.

Authors:  Tanya B Dorff; Amir Goldkorn; David I Quinn
Journal:  Ther Adv Med Oncol       Date:  2009-11       Impact factor: 8.168

Review 7.  The molecular biology of WHO grade I astrocytomas.

Authors:  Nicholas F Marko; Robert J Weil
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

Review 8.  Thinking outside the shunt-sterile CSF malabsorption in pilocytic astrocytomas: case series and review of the literature.

Authors:  J A Johnson; P J O'Halloran; D Crimmins; J Caird
Journal:  Childs Nerv Syst       Date:  2016-05-18       Impact factor: 1.475

9.  A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.

Authors:  Anuradha Banerjee; Regina I Jakacki; Arzu Onar-Thomas; Shengjie Wu; Theodore Nicolaides; Tina Young Poussaint; Jason Fangusaro; Joanna Phillips; Arie Perry; David Turner; Michael Prados; Roger J Packer; Ibrahim Qaddoumi; Sridharan Gururangan; Ian F Pollack; Stewart Goldman; Lawrence A Doyle; Clinton F Stewart; James M Boyett; Larry E Kun; Maryam Fouladi
Journal:  Neuro Oncol       Date:  2017-08-01       Impact factor: 12.300

Review 10.  Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited.

Authors:  Karl H Plate; Alexander Scholz; Daniel J Dumont
Journal:  Acta Neuropathol       Date:  2012-11-11       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.